NAV
₹39.0961
as of 29 Sept 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +11.75%
- 3Y
- +19.33%
- 5Y
- +14.79%
- Since Inception
- +13.52%
SIP returns (XIRR)
- 1Y
- +14.80%
- 3Y
- +13.37%
- 5Y
- +17.58%
- Since Inception
- +17.68%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology58.28%
- Healthcare Services34.07%
- Fertilizers & Agrochemicals5.55%
- Personal Products1.09%
- Insurance0.50%
Each sector links to the mutual funds most exposed to it.
Thinking about Tata India Pharma and Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Tata India Pharma & Healthcare Fund-Regular Plan-Growth
- 1Sun Pharmaceutical Industries Ltd8.43%
- 2Healthcare Global Enterprises Ltd6.30%
- 3Divi Laboratories Ltd5.65%
- 4Abbott India Ltd5.44%
- 5Rainbow Childrens Medicare Ltd4.47%
- 6Apollo Hospitals Enterprise Ltd4.32%
- 7Cipla Ltd4.27%
- 8Dr Reddys Laboratories Ltd4.21%
- 9Max Healthcare Institute Ltd3.80%
- 10Fortis Healthcare Ltd3.30%
What this fund does
Tata India Pharma and Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Tata India Pharma and Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Tata Mutual Fund. The fund has been operational for over 10 years.